IQVIA Holdings Inc. (IQV) has underperformed the broader market and the Health Care Select Sector SPDR Fund (XLV) over the past year and year-to-date in 2026, primarily due to margin compression and acquisition-related operating margin declines. Despite this underperformance and a recent stock tumble after Q4 results, 17 out of 22 analysts rate IQV as a “Strong Buy” or “Moderate Buy,” with a mean price target suggesting a 40.7% upside. The company’s Q4 adjusted EPS and revenue both surpassed Wall Street expectations.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Is Wall Street Bullish or Bearish on IQVIA Holdings Stock?
IQVIA Holdings Inc. (IQV) has underperformed the broader market and the Health Care Select Sector SPDR Fund (XLV) over the past year and year-to-date in 2026, primarily due to margin compression and acquisition-related operating margin declines. Despite this underperformance and a recent stock tumble after Q4 results, 17 out of 22 analysts rate IQV as a “Strong Buy” or “Moderate Buy,” with a mean price target suggesting a 40.7% upside. The company’s Q4 adjusted EPS and revenue both surpassed Wall Street expectations.